To investigate the role of individual Jun proteins in cell growth and transformation, we have used a doxycyclineinducible retroviral vector to regulate their expression in rat fibroblasts. AP-1 complexes enriched with cJun and JunB result in morphological alterations and anchorageindependent cell growth consistent with a transformationlike phenotype, whereas complexes enriched with JunD had an antiproliferative effect. These results suggest that genes regulated by both cJun and JunB are potentially involved in transformation and that they can be distinguished from those regulated by AP-1 complexes containing JunD. To identify genes regulated by cJun and JunB that may have a role in anchorage-independent growth, we investigated differential gene expression by each of the Jun family members using the Affymetrix Rat oligonucleotide microarray, RG_U34A containing approximately 8000 genes. Differentially regulated genes were identified and grouped for correlation with regulation by the different Jun proteins. A total of 33 candidate genes were found to be differentially regulated by both cJun and JunB and not by JunD. These genes have roles in cell metabolism, growth, signal transduction, migration and adhesion. We validated the differential regulation by cJun and JunB of 10 candidate genes by Northern blot analysis. Of these, eight were further characterized as potential direct targets of AP-1 regulation based on Northern blot results showing differential regulation that correlate with cJun expression. Our results show that inducible cJun and JunB expression result in anchorage-independent growth of Rat1a cells, distinct from JunD-expressing cells. This model system and a functional genomic approach enabled us to differentiate AP-1-regulated genes involved in transformation from AP-1-regulated genes known as bystander genes. This approach significantly reduces the number of bystanders and allows for the targeting of genes specifically involved in transformation.
Introduction
The transcription factor AP-1 is composed primarily of members of the Jun (c-Jun, JunB and JunD) and Fos (cFos, fosB, Fra1 and Fra2) families of proteins. These proteins have a significant role in the cellular response to a diverse number of signals initiated by UV and ionizing radiation, cytokines, mitogens, growth factors, oxidative stress and other cellular stresses. The cellular response is manifested in processes such as cell growth, differentiation and apoptosis (Shaulian and Karin, 2001) . It has been assumed that AP-1 mediates these effects by functioning as a classic transcription complex presumably by binding the TRE element (5 0 -TGACGTCA-3 0 ) in the promoters of various target genes (Angel et al., 1987 (Angel et al., , 1988 . This binding is achieved by the AP-1 complex after leucine zipper dimerization between Jun, Fos and ATF family members as heterodimers or via Jun homo-and heterodimers (Chinenov and Kerppola, 2001) . All the Jun proteins share high sequence homologies, but are distinct in their expression patterns and biologic effects. (Mechta-Grigoriou et al., 2001) .
The complex interactions between different dimerization partners as well as the interaction of the AP-1 complex with other transcription factors are presumably critical to its diverse biologic effects (Macian et al., 2001; van Dam and Castellazzi, 2001) . However, the mechanism by which AP-1 achieves its functional diversity is not completely understood. AP-1 dimers consisting of different Jun proteins differ significantly in their DNA binding affinities (Ryseck and Bravo, 1991) and transactivation potential (Chiu et al., 1989; Hirai et al., 1990; Kerppola and Curran, 1991) . While cJun has been shown to activate promoters containing a single AP-1 binding site, JunB is reported to require multiple binding sites in order to cause transcriptional activation (Deng and Karin, 1993; Passegue and Wagner, 2000) , and may inhibit the transactivation ability of cJun by forming inactive heterodimers. It has also been reported that the sequences flanking the AP-1 binding site may be key determinants in the ability of different Jun proteins to interact at that particular site (Ryseck and Bravo, 1991) . Differences in transactivation ability are attributed in part to phosphorylation of the Jun proteins that occur in the transactivation domain (Smeal et al., 1991) .
Although our understanding of the role of Jun proteins in transcriptional activation has broadened significantly in recent years, we still do not have a complete understanding of the exact role of individual Jun proteins in target gene activation and how this relates to specific biologic processes. The biologic relevance and action of Jun proteins remain largely unknown. Recent studies using mouse models have begun to address their function and are finding both differences and commonalties between the various family members (Johnson et al., 1993; Schorpp-Kistner et al., 1999; Thepot et al., 2000) . The objective of this study is to characterize the biologic effects of Jun family proteins in immortalized Rat1a fibroblast and correlate them with transcriptional target genes. This correlation will allow us to identify AP-1-regulated targets genes that have a role in a specific biologic phenotype such as transformation.
Results

Enrichment of individual Jun family proteins in the AP-1 complex by induced gene expression
To examine the role of individual Jun proteins in gene regulation, c-jun, junB and junD cDNAs were cloned into a doxycycline-inducible retroviral vector, transfected into a packaging cell lines, and resulting virus used to infect the immortalized rat fibroblast cell line Rat la. Blasticidin-resistant clones were isolated and assayed for inducible gene expression in response to doxycycline treatment. Rat1a cells containing the gene coding for inducible GFP expression was used as a control. Protein expression was analysed by Western blot analysis using Jun-specific antibodies. Representative clones with comparable levels of Jun proteins were identified and used in subsequent experiments ( Figure 1a) . Induction of the Jun proteins was detected within 2 h of doxycycline treatment and was sustained for up to 14 days without additional treatment with doxycycline (Kinoshita et al., manuscript in press) . To determine if doxycycline induction enriched for specific Jun proteins in the AP-1 complex, gel shift assays were carried out using a labelled consensus AP-1 sequence. In the presence of doxycycline, both cJun and JunD containing protein extracts had an additional slower migrating complex (II) compared to cells without doxycycline that had a single DNA-protein complex (I) (Figure 1b) . JunB containing extracts, however, showed an increase in binding to the AP-1 oligomer with predominantly one complex (I) formed. These results suggest that an altered AP-1 complex is formed in the presence of induced Jun protein expression. The exact nature and composition of the DNA-protein complexes in doxycycline-induced cells was determined by supershift analysis using antibodies against individual Jun and Fos proteins (Figure 2 ). In the GFP control cells, no significant difference was observed in nuclear extracts isolated from control and doxycycline-treated cells, and the AP-1 complex was supershifted by antibodies against cJun, JunD, Fra 1, Fos B and Fra 2. The AP-1 complexes, observed in nuclear extracts from cJun-expressing cells (complex I and II), were entirely supershifted by the cJun antibody with minor supershifts observed with the Fra2 antibody. Similar results were obtained in JunD-induced extracts showing JunD as the major component in the complex. Extracts containing JunB proteins showed a decrease in DNA binding when incubated with an antibody directed against the DNA binding region of JunB. The presence of JunB in the induced nuclear protein extract was also confirmed with an additional antibody that resulted in a complete supershift of the JunB containing complex in the presence of doxycycline (Figure 2b ). These results indicate that doxycyclineinducible gene expression is sufficient to greatly enrich for individual Jun proteins in the AP-1 complex. Thus, using the inducible system in Rat1a cells enables us to study the role of individual Jun family members in gene regulation and cellular processes in a tightly controlled manner. Induction of cJun and JunB, not JunD, result in similar morphology changes and anchorage-independent growth It has previously been reported that constitutive expression of cJun in Rat1a cells result in cellular transformation (Schutte et al., 1989) . To determine if these observations are mimicked in doxycycline-inducible conditions, we monitored the effect of inducible Jun proteins on cell morphology, proliferation and anchorage-independent growth. Doxycycline induction of cJun and JunB expression in Rat1a cells resulted in spindle-shaped and piled-up cells (Figure 3b, d ). This morphology change could be observed as early as 24 h after doxycycline treatment and was sustained up to 14 days. JunD expression, in contrast, caused no significant changes in cell morphology and these cells appeared no Figure 2 AP-1 complex compositon in cJun-, JunB-and JunD-containing nuclear protein extracts. Nuclear extracts isolated from cells grown in the absence and presence of 2 mg/ml doxycycline for 3 days were incubated with an end-labelled AP-1 probe and specific antibodies to Jun (cJun, JunB, JunD) and Fos and Fra (cFos, Fra1, FosB and Fra2) family members. Competition for AP-1 binding was performed using 100-fold molar excess of either unlabelled wild-type or mutated AP-1 oligomer probes. In cJun-induced extracts, the anti-cJun antibody caused a supershift of both complex I and II. Similar results were observed with the anti-JunD antibody in JunD-induced extracts different to GFP control cells (Figure 3f, h) . Although cJun and JunB expression resulted in morphology changes, no apparent differences in proliferation was observed in cells grown in the absence or presence of doxycycline under adherent conditions (Figure 4b, c) . The expression of JunD, however, resulted in the inhibition of cell growth (Figure 4d) . To determine the effect of individual Jun proteins on anchorage-independent growth, cells were grown in 1% methylcellulose and soft agarose for 14 days in the absence and presence of doxycycline. We had previously determined that Jun protein expression could be sustained for up to 14 days without further addition of doxycycline. In the presence of doxycycline, both cJun-and JunB-expressing cells Figure 3 cJun and JunB expression causes morphology changes while JunD has no effect. Cells grown in the absence (a, c, e and g) and presence of 2 mg/ml doxycycline for 3 days (b, d, f and h) were viewed and photographed at Â 100 magnification using phase contrast. Morphological changes including spindling and piling up was observed in cJun (b)-and JunB (d)-containing cells, whereas no effect on cell morphology in the JunD (f)-and control GFP (h)-expressing cells was detected showed significant colony formation in both methylcellulose and in soft agarose (Figure 5f , g). JunDexpressing cells had minimal ability to grow in 1% methyl cellulose and resembled control cells (Figure 5e , h). Similar results were obtained in soft-agarose cloning experiments ( Figure 5i ). These results suggest that the conditional expression of cJun and JunB can induce morphologic changes and anchorage-independent growth that are not achieved by JunD.
Overexpression of Jun proteins differentially stimulate artifical AP-1-containing promoters and demonstrate no correlation with biologic effects
To investigate the effect of conditional Jun expression on transcriptional target gene regulation, we used promoter-luciferase constructs containing AP-1 consensus sequences in transient transfection assays. Inducible cJun and JunD expression resulted in activation of an artificial promoter construct containing two AP-1 binding sites (TRE2-luciferase), while induction of JunB had no effect ( Figure 6a ). This is consistent with previous findings reporting that JunB requires at least three AP-1 binding sites in order to function as a transcriptional regulator (Chiu et al., 1989) . Similar results were obtained with a collagenase promoter construct containing a single AP-1 binding site ( Figure 6b ). These results demonstrate that transcriptional activity of artificial reporter constructs do not correlate with the cellular changes caused by Jun protein induction. This strongly suggests that target gene specificity is critical to understanding the differences between Jun family proteins.
Identification of AP-1 transcriptional targets
To identify AP-1 transcriptional targets associated with the anchorage-independent growth observed in cJunand JunB-expressing cells, we performed microarray analysis using Affymetrix oligonucleotide arrays, Rat U34A, containing approximately 7000 known genes and 1000 EST clusters. Total RNA was extracted from cells grown for 24 h in suspension in the absence and presence of doxycycline. Genes that were reproducibly regulated in two independent experiments for each cell line were selected for further analysis. Differentially regulated genes obtained in cJun-and JunB-expressing cells were compared to that obtained for JunD-expressing cells to identify candidate genes that might be necessary and/or sufficient in nonadherent growth. In all, 33 genes met the criteria of reproducible regulation (1.7-fold up-or downregulated) in both cJun-and JunB-expressing cells compared to JunD-expressing cells (Table 1) . These genes have been reported to play roles in metabolism, signal transduction, growth, adhesion, migration and invasion, all of which are essential for the process of transformation. The differential regulation of 10 candidate genes identified by microarray analysis was validated by Northern blotting using RNA isolated from cells grown in suspension in the absence and presence of doxycycline. The results confirm increased expression of Fit-1, p55CDC, caveolin1, Pak3, CYP1B1, PP2A, sgk and TCP-1 (Figure 7a ) and decreased expression of Col1A1 and Fibulin5 (Figure 7b ) in cJunand JunB-expressing cells with minimal regulation by JunD. To determine whether any of the above genes are direct transcriptional targets of AP-1 containing cJun, Northern analysis was performed with RNA extracted from cells grown in suspension in the absence and presence of doxycycline for 4 and 8 h. These time points were chosen based on a time course of cJun expression. cJun was maximal at approximately 4 h after doxycyline treatment and was sustained for up to 14 days (Kinoshita et al., manuscript in press ). The results suggest that sgk, caveolin 1, p55CDC, CYP1B1, stathmin, PP2A and Fit-1 may be candidates for direct regulation by AP-1 complexes containing cJun (Figure 8) .
A comparison of differential gene regulation by the Jun family proteins in Rat1a cells provide a useful model that allow for the identification of AP-1 target genes that associate with specific biologic phenotypes. This model, in addition to providing insight into genes involved in transformation as described in this study, may be useful in addressing questions regarding transcriptional regulation by individual Jun proteins. These genes are categorized by differential regulation that is unique to, and shared by different Jun proteins (Venn diagram, Figure 9 ). Of the 184 genes identified as differentially regulated, a surprisingly small subset (28 genes) shows regulation by all the Jun proteins. Transcriptional regulation by individual Jun proteins appear to be slanted toward cJun and JunB (26 and 42 genes, respectively) with JunD showing regulation of 18 genes. These results support the theory that 
Discussion
The objective of this study was to characterize and compare the biologic and transcriptional actions of Jun family members. We hypothesized that the transcription complex, AP-1, mediates its diverse biologic effects by its varied composition and the transcriptional target specificity of its individual component proteins. By using conditional Jun protein expression, we demonstrate that cJun and JunB induction result in a phenotype consistent with cellular transformation, that is, changes in cell morphology, proliferation and anchorage-independent growth. Similar results have been obtained in studies utilizing primary mouse cells (Castellazzi et al., 1990 (Castellazzi et al., , 1991 showing that JunB-expressing cells can form colonies in agar albeit to a lesser extent than those of cJun-expressing cells (Mechta et al., 1997) . JunD induction, in contrast, inhibits cell growth and had no effect on cell morphology and nonadherent cell growth.
Similar observations have been reported (Pfarr et al., 1994) , showing that NIH3T3 cells overexpressing JunD accumulate in G1 and hence having a slower proliferation rate.
We hypothesized that the biologic phenotype of anchorage-independent cell growth achieved in cJunand JunB-, and not JunD-expressing cells, is likely to occur via the regulation of similar transcriptional targets that will differ from those regulated by JunD. This hypothesis was based on the finding that the enrichment of individual Jun proteins in the AP-1 complex results in biologic end points that are unique to specific Jun proteins (e.g. the inhibition of cell growth in JunDexpressing cells and ones that are shared by different Jun proteins (e.g. transformation-like phenotype in cJunand JunB-expressing cells). We therefore predicted that AP-1 regulated genes, which correlate with these phenotypes, could be distinguished on the basis of transcriptional regulation.
Since cJun and JunB induction result in anchorageindependent growth, the focus of this study was to identify genes regulated by these Jun family members but not JunD. A recent study reported that JunB can Figure 5 Anchorage-independent cell growth in the absence and presence of Jun proteins. (a) Cells were grown in the presence and absence of 2 mg/ml doxycycline in 1% methylcellulose on polyheme-coated dishes to mimic growth in soft agarose. After 14 days, the cells were stained with 1 mg/ml p-iodonitrotetrazolium violet for 16 h at 371C. Bright-field micrographs were taken at Â 100 magnification. Growth as observed by staining for viable cells was minimal in the absence of doxycycline (a-d), but significant colony formation was observed in cJun (f)-and JunB (g)-induced cells. JunD-induced cells (h) behaved similarly to the untreated control (d) and GFP cells (e). (i) Soft agarose colony formaton in untreated and doxycycline-induced cells was determined as described in Materials and methods. The number of colonies formed were scored after 14 days using a colony counter. Soft agarose cloning is expressed relative to uninduced controls. Results shown are representative of three independent experiments performed in triplicate replace cJun function in mouse development and cell proliferation (Passegue et al., 2002) . This finding supports our theory that cJun and JunB may share transcriptional targets which have a role proliferation and transformation. Early reports of cJun and JunB as early response genes eluded to the possibility that these Jun proteins share function presumably by sharing transcriptional targets (Lamph et al., 1988; Mellstrom et al., 1991; Naranjo et al., 1991) . To date, very few AP-1 transcriptional targets involved in deregulated cell growth have been identified. The identification of such genes and their role in the transformation is however complicated by AP-1-regulated genes known as 'bystanders'. These are AP-1-regulated genes that have no role in cell growth and transformation. Of the AP-1-regulated genes identified thus far, four have been reported to induce a change in cellular phenotype (Hartl et al., 2001; Vogt, 2001) . Two v-jun upregulated genes in CEF, HB-EGF and JAC causes partial transformation (Fu et al., 1999; Hartl et al., 2001) , while reintroduction of v-jun downregulated genes, SPARC and SSeCKS, result in partial reversion of vJun-induced transformation (Cohen et al., 2001; Vial et al., 2000) . In contrast to vJun regulation in CEFs, SPARC is upregulated in cJun-overexpressing MCF7 cells and it has been associated with motility and invasion of these cells (Briggs et al., 2002) . The fact that so few AP-1-regulated genes identified to date are conclusively linked to transformation emphasizes the importance of utilizing new technologies such as microarray analysis to expand our knowledge for the role of AP-1 in transformation. Based on the hypothesis that gene regulation by specific Jun proteins will result in unique biologic end points, we used this observation in microarray analysis to distinguish between bystander genes and those that correlate with a specific phenotype, for example, transformation. Of all the genes identified, a small subset of 33 genes were identified as potential cJun and JunB targets. A total of 10 of these genes were further validated by Northern blot analysis confirming their differential regulation in cJun-and JunB-induced cells. Of these, a number are potentially direct transcriptional targets of AP-1 and these are currently being further characterized to determine their role in cell growth and transformation. Based on published reports, we predict that a number of these genes may be essential to proliferation and survival, which are integral to cellular transformation. Expression of p55CDC for example is elevated in cycling cells and has been shown to be involved in G2/M cell cycle regulation (Weinstein et al., 1994; Weinstein, 1997) . Increased p55CDC expression has also been detected in immortalized oral keratinocytes and may be associated with the early stages of oral carcinogenesis (Nishitani et al., 2002) . It is generally accepted that an increase in kinase activity accompanies anchorageindependent growth and transformation. We have identified at least two kinases, PAK3 and sgk, as potential AP-1 targets. Both are serine/threonine kinases and sgk, in particular, is regulated in an immediate-early manner in response to serum, suggesting that it may be involved in G0 to S transition and entry into the cell cycle (Webster et al., 1993) . Sgk is also transcriptionally regulated in rat mammary tumor cells by serum under proliferative conditions and is required for cell survival (Buse et al., 1999; Mikosz et al., 2001) . The link between caveolin-1, a putative tumor suppressor, and cell growth is more contentious. Conflicting evidence exists for the role of caveolin-1 in anchorage-independent growth and invasion. While caveolin-1 inhibits anchorage-independent growth and invasion in 3T3 and MCF-7 breast cancer cells (Engelman et al., 1997; Fiucci et al., 2002) , it increases the metastasis of lung adenocarcinoma (Ho et al., 2002) and esophageal carcinoma (Kato et al., 2002) . This apparent contradiction may be related to its function as an inhibitor of apoptosis (Timme et al., 2000) and a promoter of survival/clonal growth and metastasis of prostate cancer cells (Li et al., 2001) . Presumably, the upregulation of genes required for proliferation, survival and inhibition of apoptosis might all be essential for anchorage-independent growth. Interestingly, a number of genes coding for extracellular (Semb and Christofori, 1998; Zarka et al., 2003) and the loss of their expression in lung cancer is associated with tumorigenicity (Zhong et al., 2001) . Similarly, the expression of type I collagen has been reported to inhibit proliferation as well as colony formation in soft agar (Lim et al., 1994; Henriet et al., 2000; Wilson et al., 2002) , and type IV collagen in basement membranes has antitumor properties and inhibits tumor growth (Maeshima et al., 2000) . Based on their known function as inhibitors of proliferation, it is reasonable to assume that the downregulation of these adhesion molecules may be essential to anchorageindependent growth and the morphology changes associated with AP-1 deregulation. These conjectures, however, will have to be proven by additional studies in order to determine the precise role of these genes in the phenotypes observed in this study. A number of studies have shown that re-expression of candidate genes results in a partially transformed phenotype (Fu et al., 1999; Hartl et al., 2001) or partial reversion of the transformed phenotype (Vogt, 2001) , it is likely that this phenotype is achieved by the regulation of combination of genes. It is therefore probable that combinations of cJun-and JunB-regulated genes identified in this study will have to be reintroduced into cells to obtain significantly transformed cells.
Our study shows that by conditional expression of the Jun proteins, we are able to characterize biologic phenotypes that are distinct and shared by individual Jun proteins. We conclude that the conditional expression of the various Jun proteins allow for the identification of transcriptional target genes that correlate with different biologic responses as well as the identification of targets that may be directly and indirectly regulated by AP-1.
Materials and methods
Retroviral plasmid construction
EcoR1 fragments of cJun and JunD were cloned into pBluescript KS and confirmed by sequencing. Fragments in the sense orientation were released by Xho1/Not1 digestion and cloned into Xho1/Not1-digested retroviral vector, pLRT (Watsuji et al., 1997) . JunB was amplified by PCR from a wild-type containing plasmid using a 5 0 primer containing a Xho1 digestion site and the 3 0 primer containing a Not1-digested site. The PCR product was cloned into pCR2.1 using the Invitrogen TOPO kit. After confirming the clones by sequence Genes regulated by Jun family members VD Leaner et al analysis, the fragment was released by Xho1/Not1 digestion and cloned into pLRT as described above.
DNA transfection and generation of c-jun, JunB and JunD conditionally transformed Rat1a fibroblasts Retroviral plasmids, pLRT-c-jun, JunB and JunD were transfected into Phoenix A cells, a retroviral packaging cell line, using the calcium phosphate transfection method (Sambrook et al., 1989) . At 24 h post-transfection, fresh culture media was applied and the cells incubated for an additional 48 h before harvesting the retroviral containing media. Rat1a fibroblasts at approximately 50-80% confluence were then infected with c-jun, JunB and JunD containing retrovirus in cell culture media containing 10% FBS for 48 h at 371C. The cells were split at appropriate dilutions and treated with 8 mg/ml blasticidin. Blasticidin-restistant clones were selected and screened for inducible RNA and protein expression using 2 mg/ml doxycycline for 48 h. Clones with the lowest background and highest inducible gene expression were used in subsequent experiments.
Cell culture and doxycycline induction
Phoenix A cells and Rat1a fibroblasts were grown in Dulbecco's MEM (GIBCO/BRL, Burlington, ON, Canada) containing 10% fetal calf serum. Rat1a transfectant clones were maintained in the presence of 5 mg/ml blasticidin. For subsequent experiments, subconfluent cells were trypsinized with 0.5% trypsin/0.53 EDTA in Hanks-balanced salt solution (Tryp/EDTA; GIBCO/BRL) and plated in 10% FBS containing media in the absence or presence of 2 mg/ml doxycycline for 24-72 h to induce gene expression.
Total cell and nuclear protein preparation
Total cell protein was isolated from cells grown in the absence and presence of doxycycline using RIPA lysis buffer (150 mm NaCl, 1% Triton X-100, 1% deoxycholate, 0.1% SDS, 10 mm Tris. PH 7.4, containing 0.1 mm PMSF, 100 mg/ml aprotinin and 100 mg/ml leupeptin). The lysed cells were sonicated, centrifuged to removed debri and protein concentrations determined using the Bradford assay (Biorad). Samples were stored at À201C until required. Doxycycline regulated cJun and JunD gene expression was monitored by Western blot analysis using a pan-Jun antibody (sc44) at dilutions recommended by the supplier (Santa Cruz Biotechnology). For inducible JunB expression the antibody sc46 was used. Nuclear proteins were extracted from cells as treated above using a modified method of Dignam et al. (1983) . Briefly, cells grown in 100 mm diameter tissue culture dishes were harvested in cold Figure 7 Northern blot analysis to validate cJun-and JunBregulated genes identified by microarray analysis. Total RNA (2 mg) from cells grown in nonadherent conditions in the absence and presence of 2 mg/ml doxycycline for 72 h was used in Northern blots. Representative clones from the subset of genes identified as differentially regulated by cJun and JunB (Table 1) were used as probes to detect upregulated (a) and downregulated (b) genes Figure 8 Identification of direct AP-1 transcriptional target genes. RNA was extracted from control and cJun-expressing cells grown in suspension after 4 and 8 h incubation with 2 mg/ml doxycycline. RNA (2 mg) was used in Northern blot analysis with the relevant probes PBS using a cell scraper. The cells were pelleted and resuspended in five packed cell volumes of a buffer containing 10 mm HEPES (pH 7.9), 1.5 mm MgCl 2 , 10 mm KCl, 0.5 mm DTT and allowed to swell on ice for 10 min. By slow uptake and rapid ejection (10 Â ) through a 25G needle, the cell membranes were broken, nuclei pelleted by centrifugation and resuspended in a small volume of buffer containing 20 mm HEPES (pH 7.9), 25% glycerol, 0.45 m NaCl, 1.5 mm MgCl 2 , 0.2 mm EDTA, 0.5 mm PMSF, 100 mg/ml aprotinin and 1 mg/ ml leupeptin. This was then rotated in the cold for 30 min and dialyzed for 2 h at 41C against 50 volumes of buffer (20 mm HEPES (pH 7.9), 25% glycerol, 0.1 m KCl, 0.2 mm EDTA, 0.5 mm PMSF, 1 mg/ml each of aprotinin and leupeptin. After centrifugation, the supernatants were stored at À701C. Protein concentrations were determined as above.
Mobility shift assays
Crude nuclear extract (5 mg) was incubated with 2 mg of poly dIdC/poly dI/dC and 4 ml of incubation buffer (IB) (100 mm HEPES (pH 7.9), 250 mm KCl, 2.5 mm EDTA, 5 mm MgCl 2 , 20% Ficoll 400) in a volume of 20 ml for 10 min on ice prior to the addition of double-stranded AP-1 oligomers labelled with [g-32 P]ATP. The protein-probe mixtures were incubated on ice for a further 30 min. The DNA-protein complexes were separated on nondenaturing 5% polyacrylamide gels at 180 V for 2-3 h at 41C in 0.5 Â TBE. For supershift experiments, antibodies (sc45 Â , sc74 Â , sc52 Â , sc605 Â , sc46 Â , sc7203, sc73 Â ) were added to the protein : dI/C/IB mixture and incubated for 20 min at room temperature before adding the labelled probe. Gels were electrophoresed as above.
Transformation and proliferation assays
Adherent cell proliferation in 10% FBS containing cell growth media in the absence and presence of 2 mg/ml doxycycline was determined by MTT assay (Promega). The cells were seeded in 96-well Falcon plates and incubated in the absence or presence of 2 mg/ml doxycycline. To determine anchorage-independent cell growth, two assays were used. The cells were grown in 1% methylcellulose in 10% FBS containing media and plated on polyheme-coated dishes to prevent adhesion to the dish. Growth was allowed for 14 days in the absence and presence of doxycycline, and the cells were stained with 1 mg/ml piodonitrotetrazolium violet for 16 h at 371C to detect live cells in colonies. The colonies were photographed under bright-field microscopy at Â 100 magnification. Soft agarose colony formation was also used as previously described. 1 Â 10 4 cells were plated in triplicate in 0.35% agarose in 10% FBS containing media (with and without 2 mg/ml doxycycline) on a 0.7% agarose base in six-well plates. After 14 days, the soft agarose colony formation was counted using a colony counter.
Reporter assays
Transient transfection assays were performed using FuGene6 reagent. In all, 1 mg of TRE 2 -Luciferase plasmid and 0.5 mg CMV-b-galactosidase plasmid in FuGene6 reagent was added to cells in a six-well plate. The transfected cells were incubated for 24 h, trypsinized and split 1 : 6. Three plates were treated with 2 mg/ml doxycycline and three without. The cells were incubated for an additional 48 h, the proteins harvested in passive lysis buffer (PROMEGA) and luciferase and bgalactosidase activity determined as previously described.
Northern blot analysis
Total RNA was isolated from uninduced and doxycyclineinduced cells using Trizol Reagent (Life Technologies, Inc.) and 2 mg used in Northern blot analysis. The probes were generated by polymerase chain reaction with M13 forward and M13 reverse primers using cDNA clones obtained from Research Genetics, Huntsville, AL, USA. Jun family probes were generated by Xho1/Not1 restriction digest of pBlue-c-jun, pBlue-JunD and pCR2.1-JunB. Hybridizations were performed in UltaHyb solution (Ambion) according to the manufacturer's protocol.
Microarray analysis
Total RNA was extracted from cells grown in suspension in 10% FBS containing media in the absence and presence of doxycycline for 24 h using Trizol Reagent (Life Technologies, Inc.). mRNA (5 mg) was used for in vitro transcription with a T7(dT) 24 primer and biotinylated ribonucleotide probes prepared with T7 RNA polymerase. After fragmentation, the resultant probes were hybridized to a rat oligonucleotide microarray RG_U34A (Affymetrix, Santa Clara, CA, USA) according to the manufacturer's protocol. Each hybridization reaction was repeated and the data from the control samples used as baseline expression for comparison with the doxycycline-treated samples. Comparisons of gene expression between control and doxycycline-treated cells was performed with the GeneChip software. Signal intensities were normalized to the total intensity and genes excluded from the outliers if the decision algorithm used negative values of average differences. Genes that were reproducibly regulated between were selected and those with an average 1.7-fold change in expression were used to group genes differentially regulated by the Jun proteins. Figure 9 Venn diagram of the number of genes regulated by the different Jun proteins. Genes were assigned as differentially regulated if the expression ratio (control to Jun presence) was X1.7-fold up-or downregulated in duplicate experiments and the GeneChip Analysis software (Affymetrix) change call of PI (present and increased) or PD (present and decreased) used. Data set comparisons were done in Microsoft Excel using 1.7-fold changes as criteria for assignment to a particular subset
